Goldline Pharmaceutical IPO is to open on May 12, 2026. It is an SME IPOĀ that will raise ā¹12 crores. The Goldline Pharmaceutical IPOĀ price band is fixed at ā¹41 to ā¹43 with a market lot of 6000 Shares.
Goldline Pharmaceutical IPO GMP Live Rates day by day.
| Date | IPO GMP | GMP Trend | Gain |
| 7 May | ā¹- | – | -% |
Goldline Pharmaceutical IPO Details
| IPO Open Date | May 12, 2026 |
| IPO Close Date | May 14, 2026 |
| Face Value | ā¹10 Per Equity Share |
| IPO Price Band | ā¹41 to ā¹43 Per Share |
| Issue Size | Approx ā¹12 Crores |
| Fresh Issue | Approx ā¹12 Crores |
| Issue Type | Book build Issue |
| IPO Listing | BSE SME |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Goldline Pharmaceutical IPO Dates
| IPO Open Date: | May 12, 2026 |
| IPO Close Date: | May 14, 2026 |
| Basis of Allotment: | May 15, 2026 |
| Refunds: | May 18, 2026 |
| Credit to Demat Account: | May 18, 2026 |
| IPO Listing Date: | May 19, 2026 |
| IPO Bidding Cut-off Time: | May 14, 2026 – 5 PM |
Business Overview
To be updated soon
Goldline Pharmaceutical IPO GMP aka Grey Market Premium FAQs:
What is Goldline Pharmaceutical IPO GMP Today?
Goldline Pharmaceutical IPO GMP is ā¹- as of today.
What is Goldline Pharmaceutical IPO Expected Returns?
Goldline Pharmaceutical IPO Expected Returns is -%.
Disclaimer:
- IPO Grey Market Premium (Goldline Pharmaceutical IPO GMP) mention is valid for the specific date as mentioned in the header.
- We are not buying and selling IPO forms on IPO Grey Market.
- Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
- Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.
